GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹91 Cr | ₹64 Cr | ₹39 Cr | ₹40 Cr | ₹11 Cr |
What is the latest Cash Flow from Operating Activities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹91 Cr |
| Mar2024 | ₹64 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹11 Cr |
How is Cash Flow from Operating Activities of GUJARAT THEMIS BIOSYN Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹91 Cr | 41.76 | |
| Mar2024 | ₹64 Cr | 62.66 | |
| Mar2023 | ₹39 Cr | -2.08 | |
| Mar2022 | ₹40 Cr | 282.80 | |
| Mar2021 | ₹11 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹2,965.9 Cr | -7.3% | -13.2% | 14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.7% | 4% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.7% | -1.8% | 10.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -3.7% | 4.5% | 42.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3% | 0% | 15.4% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -2.6% | -2.3% | -10.1% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -7.3% |
-13.2% |
14% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses